ArticleThe Journal of endocrinology2026
The impact and potential mechanisms of long noncoding RNA ENST00000521141.1 on human white adipocyte differentiation.
Article in The Journal of endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Accumulation of visceral white adipose tissue leads to central obesity and is associated with insulin resistance and increased risk of metabolic disease. lncRNAs have been reported to regulate the growth and development of adipocytes, providing new clues for the prevention and treatment of obesity. In the present study, we identified numerous dysregulated lncRNAs by microarray analysis between human differentiated adipocytes and preadipocytes. In addition, we focused on the lncRNA ENST00000521141.1 (abbreviated as lncRNA521141) confirmed by qRT-PCR to be enriched in differentiated adipocytes. Lentivirus-mediated knockdown of lncRNA521141 significantly suppressed adipogenesis as evidenced by reduced lipid accumulation, triglyceride content, and key adipogenic markers expression, while lentivirus-mediated lncRNA521141 overexpression showed no significant effect. Given that lncRNA521141 did not alter the expression of the neighboring gene PEBP4, fluorescence in situ hybridization was employed to elucidate the cellular localization of lncRNA521141, revealing its predominant distribution in the nucleus. RNA-sequencing and western blot analysis further revealed the potential involvement of the PI3K-Akt and thyroid hormone synthesis pathways in lncRNA521141-mediated adipogenic inhibition. Among the differentially expressed genes, PDGFRA expression was significantly upregulated following lncRNA521141 silencing and was closely associated with adipocyte differentiation. Rescue experiments confirmed that knockdown of PDGFRA expression after lncRNA521141 silencing alleviated the inhibitory effects of the reduced lncRNA521141 expression on adipocyte differentiation. In summary, the present study identified lncRNA521141 as a key regulator of adipogenic differentiation in human preadipocytes and elucidated its potential regulatory mechanism, thereby providing new insights and potential intervention targets for treating obesity and its related diseases.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.